BioLargo acquires breakthrough stem cell therapy technology to expand medical product portfolio

Stock Information for Biolargo Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Biolargo Inc

EPA Adds PFAS to CERCLA (Superfund) Law, Favoring Low-Waste Systems like BioLargo's AEC
BioLargo PFAS Removal Technology Meets New US Drinking Water Standards
AI & Technology Hybrid Investor Conference Agenda: Presentations Now Available for Online Viewing
AI & Technology Hybrid Investor Conference Presented by Water Tower Research Agenda Announced for April 10 and 11
BioLargo Achieved 108% Year-Over-Year Revenue Growth in 2023
BioLargo Year-End 2023 Earnings Results Webcast and Conference Call on Tuesday, April 2, 2024 - 5:00 PM Eastern Time
Gabelli Funds to Host 10th Annual Waste & Environmental Services Symposium Thursday, April 4, 2024
BioLargo to Present at The LD Micro Invitational XIV

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.